Correlation Engine 2.0
Clear Search sequence regions


  • allele (1)
  • anhedonia (7)
  • brain (1)
  • case control studies (1)
  • diagnosis (6)
  • gene (1)
  • GLP 1 receptor (1)
  • GLP- 1Rs (6)
  • GLP1R protein (1)
  • hamilton (2)
  • humans (1)
  • protein human (1)
  • reward (7)
  • rs1042044 (4)
  • sex (1)
  • suggests (2)
  • task (4)
  • Sizes of these terms reflect their relevance to your search.

    Glucagon-like peptide-1 receptors (GLP-1Rs) are widely expressed in the brain. Evidence suggests that they may play a role in reward responses and neuroprotection. However, the association of GLP-1R with anhedonia and depression diagnosis has not been studied. Here, we examined the association of GLP-1R polymorphisms with objective and subjective measures of anhedonia, as well as depression diagnosis. Objective [response bias assessed by the probabilistic reward task (PRT)] and subjective [Snaith-Hamilton Pleasure Scale (SHAPS)] measures of anhedonia, clinical variables and DNA samples were collected from 100 controls and 164 patients at McLean Hospital. An independent sample genotyped as part of the Psychiatric Genomics Consortium (PGC) was used to study the effect of putative GLP-1R polymorphisms linked to response bias in PRT on depression diagnosis. The C allele in rs1042044 was significantly associated with increased PRT response bias, when controlling for age, sex, case-control status and PRT discriminability. AA genotype of rs1042044 showed higher anhedonia phenotype based on SHAPS scores. However, analysis of PGC major depressive disorder data showed no association between rs1042044 and depression diagnosis. Findings suggest a possible association of rs1042044 with anhedonia but no association with depression diagnosis.

    Citation

    Hale Yapici-Eser, Vivek Appadurai, Candan Yasemin Eren, Dilek Yazici, Chia-Yen Chen, Dost Öngür, Diego A Pizzagalli, Thomas Werge, Mei-Hua Hall. Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis. Acta neuropsychiatrica. 2020 Aug;32(4):218-225

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32213216

    View Full Text